From todays announcement regarding SubB2M cancer-specific probe.
"BARD1 had a post-Sienna acquisition cash position of approximately $10.4 million at 31 July 2020 that will be used to fund its ongoing research, development and commercial programs"
Wild
- Forums
- ASX - By Stock
- IIQ
- Ann: Appendix 4E and Annual Report to Shareholders
Ann: Appendix 4E and Annual Report to Shareholders, page-40
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.0¢ |
Change
0.005(0.92%) |
Mkt cap ! $60.92M |
Open | High | Low | Value | Volume |
56.5¢ | 56.5¢ | 55.0¢ | $15.12K | 26.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13918 | 55.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13918 | 0.550 |
2 | 15062 | 0.545 |
4 | 29113 | 0.540 |
1 | 10000 | 0.535 |
2 | 5000 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 15000 | 1 |
0.570 | 26027 | 2 |
0.585 | 10000 | 1 |
0.590 | 5000 | 1 |
0.595 | 10000 | 1 |
Last trade - 15.16pm 06/09/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |